Buy Relugolix 120mg Tablets for Advanced Prostate Cancer Markets Worldwide
Relugolix 120mg Tablets are an oral gonadotropin-releasing hormone (GnRH) receptor antagonist used in androgen deprivation therapy (ADT) for adult patients with advanced prostate cancer. The medicine is designed for rapid testosterone suppression without the initial testosterone surge commonly associated with some injectable therapies. It is commonly marketed under the brand name Orgovyx.
What is Relugolix 120mg?
Relugolix is an oral anti-cancer medication indicated primarily for advanced and hormone-sensitive prostate cancer. It works by blocking GnRH receptors, reducing testosterone production that fuels prostate cancer growth. The once-daily tablet format provides a non-injectable treatment option.
Key Product Details
Product Name: Relugolix Tablets 120mg
Active Ingredient: Relugolix
Strength: 120mg Tablets
Therapeutic Category: Oncology / Hormonal Therapy
Dosage Form: Oral Tablets
Treatment Area: Advanced Prostate Cancer
Mechanism: GnRH Receptor Antagonist
Administration: Once Daily Oral Therapy after loading dose protocol
Benefits of Relugolix 120mg Tablets
Oral alternative to injectable androgen deprivation therapy
Rapid testosterone suppression
No initial testosterone flare associated with many GnRH agonists
Convenient daily administration
Suitable for long-term prostate cancer management programs
Faster testosterone recovery reported after discontinuation compared with some alternatives
Indications
Relugolix 120mg Tablets are indicated for:
Advanced prostate cancer treatment
Hormone-sensitive prostate cancer management
Androgen deprivation therapy (ADT) programs
Long-term testosterone suppression protocols in adult male patients
Dosage Information
Typical treatment initiation involves:
Loading Dose: 360mg on Day 1
Maintenance Dose: 120mg once daily thereafter
Can be taken with or without food
Tablets should be swallowed whole without crushing or chewing
Global Export Supply for International Buyers
We support oncology medicine sourcing and pharmaceutical export inquiries for buyers, importers, distributors, hospitals, oncology centers, procurement agencies, and wholesalers in:
United States
Germany
United Kingdom
United Arab Emirates
Brazil
South Africa
Packaging and Supply Options
Hospital Supply Programs
Bulk Procurement Support
Institutional Tenders
Distributor Partnerships
Private Label / Export Documentation Support
International Shipping Assistance
Frequently Asked Questions
Is Relugolix 120mg used for prostate cancer?
Yes. Relugolix tablets are indicated for advanced prostate cancer treatment in adults through testosterone suppression therapy.
How is Relugolix different from injectable hormone therapy?
Relugolix is an oral therapy and may avoid the initial testosterone flare associated with certain GnRH agonist injections. Community discussions also frequently mention convenience and quicker recovery after treatment cessation.
Who buys Relugolix internationally?
Hospitals, oncology distributors, procurement agencies, cancer centers, pharmaceutical importers, and specialty wholesalers commonly source advanced oncology medicines globally.
Important: Relugolix is a prescription oncology medicine. Product use, registration requirements, and import regulations vary by country and should follow local regulatory requirements.
Relugolix 120mg Tablets are an oral gonadotropin-releasing hormone (GnRH) receptor antagonist used in androgen deprivation therapy (ADT) for adult patients with advanced prostate cancer. The medicine is designed for rapid testosterone suppression without the initial testosterone surge commonly associated with some injectable therapies. It is commonly marketed under the brand name Orgovyx.
What is Relugolix 120mg?
Relugolix is an oral anti-cancer medication indicated primarily for advanced and hormone-sensitive prostate cancer. It works by blocking GnRH receptors, reducing testosterone production that fuels prostate cancer growth. The once-daily tablet format provides a non-injectable treatment option.
Key Product Details
Product Name: Relugolix Tablets 120mg
Active Ingredient: Relugolix
Strength: 120mg Tablets
Therapeutic Category: Oncology / Hormonal Therapy
Dosage Form: Oral Tablets
Treatment Area: Advanced Prostate Cancer
Mechanism: GnRH Receptor Antagonist
Administration: Once Daily Oral Therapy after loading dose protocol
Benefits of Relugolix 120mg Tablets
Oral alternative to injectable androgen deprivation therapy
Rapid testosterone suppression
No initial testosterone flare associated with many GnRH agonists
Convenient daily administration
Suitable for long-term prostate cancer management programs
Faster testosterone recovery reported after discontinuation compared with some alternatives
Indications
Relugolix 120mg Tablets are indicated for:
Advanced prostate cancer treatment
Hormone-sensitive prostate cancer management
Androgen deprivation therapy (ADT) programs
Long-term testosterone suppression protocols in adult male patients
Dosage Information
Typical treatment initiation involves:
Loading Dose: 360mg on Day 1
Maintenance Dose: 120mg once daily thereafter
Can be taken with or without food
Tablets should be swallowed whole without crushing or chewing
Global Export Supply for International Buyers
We support oncology medicine sourcing and pharmaceutical export inquiries for buyers, importers, distributors, hospitals, oncology centers, procurement agencies, and wholesalers in:
United States
Germany
United Kingdom
United Arab Emirates
Brazil
South Africa
Packaging and Supply Options
Hospital Supply Programs
Bulk Procurement Support
Institutional Tenders
Distributor Partnerships
Private Label / Export Documentation Support
International Shipping Assistance
Frequently Asked Questions
Is Relugolix 120mg used for prostate cancer?
Yes. Relugolix tablets are indicated for advanced prostate cancer treatment in adults through testosterone suppression therapy.
How is Relugolix different from injectable hormone therapy?
Relugolix is an oral therapy and may avoid the initial testosterone flare associated with certain GnRH agonist injections. Community discussions also frequently mention convenience and quicker recovery after treatment cessation.
Who buys Relugolix internationally?
Hospitals, oncology distributors, procurement agencies, cancer centers, pharmaceutical importers, and specialty wholesalers commonly source advanced oncology medicines globally.
Important: Relugolix is a prescription oncology medicine. Product use, registration requirements, and import regulations vary by country and should follow local regulatory requirements.
Keywords
